IRCT20181113041646N1招募中3 期
Comparison of duloxetine and pregabalin Effects on invalidation score and depression in Patients with Fibromyalgia.
Rasht University of Medical Sciences0 个研究点目标入组 68 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- Female
入选标准
- •Patients must meet the American College of Rheumatology criteria for fibromyalgia (ACR2010).
- •A rheumatologist confirm diagnosis of fibromyalgia.
排除标准
- •Age younger than 18 or older than 65 years old
- •Pregnancy .
- •Taking MAOIs (monoamine oxidase inhibitors) in the 14 days before study.
- •Cases of chronic liver disease, severe renal failure and uncontrolled narrow angle glaucoma.
- •History of sensitivity to Pregabalin and its components.
- •History of sensitivity to Duloxetine and its components.
研究者
相似试验
已完成
不适用
Identification of the probable mechanisms of Duloxetine and Pregabalin involving in treatment of neuropathic pain of type 2 diabetic patientsCondition 1: Non-insulin-dependent diabetes mellitus. Condition 2: Pain due to diabetic polyneuropathy. Condition 3: Autonomic neuropathy.Non-insulin-dependent diabetes mellitusDiabetic polyneuropathyAutonomic neuropathy in endocrine and metabolic diseasesG63.2*IRCT2017012932277N1The vice chancellor for research affairs of Shahid Beheshti University of Medical Sciences60
尚未招募
2 期
Comparison of Pregabalin with Duloxetine for Pain management.CTRI/2020/03/024306Department of Anaesthesiology and Critical Care JNMCH AMU Aligarh
已完成
2 期
Effect and safety of pregabalin and duloxetine on chemotherapy-related peripheral neurotoxicity for patients with advanced gastric and breast cancer.JPRN-UMIN000015872Osaka Medical College Hospital60
尚未招募
不适用
Comparing effect of two medications pregabalin and duloxetine for tingling and numbness in patients with long lasting low back paiCTRI/2022/05/042387Post Graduate Institute of Medical Education and research
尚未招募
4 期
A clinical trial to study the effects of two drugs, pregabalin and duloxetine, in patients with chemotherapy-induced peripheral sensory neuropathy.CTRI/2024/06/069398on sponsored